Rankings
▼
Calendar
DXR
Daxor Corporation
$57M
FY 2015 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
-$7M
-83.6% YoY
Gross Profit
-$8M
104.2% margin
Operating Income
-$8M
105.9% margin
Net Income
-$9M
122.9% margin
EPS (Diluted)
$-2.38
Cash Flow
Operating Cash Flow
$19M
Free Cash Flow
$19M
Stock-Based Comp.
$7,535
Balance Sheet
Total Assets
$21M
Total Liabilities
$6M
Stockholders' Equity
$14M
Cash & Equivalents
$2M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
-$7M
-$4M
-83.6%
Gross Profit
-$8M
-$4M
-91.4%
Operating Income
-$8M
-$5M
-74.9%
Net Income
-$9M
-$976,703
-836.5%
← Q4 2014
All Quarters
Q2 2015 →
DXR FY 2015 Earnings — Daxor Corporation Revenue & Financial Results | Market Cap Arena